Notice: This company has been marked as potentially delisted and may not be actively trading. Hudson Executive Investment (HEC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends HEC vs. DCGO, INNV, EUDA, PIII, KDLY, VSEE, ATPC, UPHL, BTTX, and LFSTShould you be buying Hudson Executive Investment stock or one of its competitors? The main competitors of Hudson Executive Investment include DocGo (DCGO), InnovAge (INNV), EUDA Health (EUDA), P3 Health Partners (PIII), Kindly MD (KDLY), Vsee Health (VSEE), Agape ATP (ATPC), UpHealth (UPHL), Better Therapeutics (BTTX), and LifeStance Health Group (LFST). Hudson Executive Investment vs. DocGo InnovAge EUDA Health P3 Health Partners Kindly MD Vsee Health Agape ATP UpHealth Better Therapeutics LifeStance Health Group DocGo (NASDAQ:DCGO) and Hudson Executive Investment (NASDAQ:HEC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, risk, earnings, profitability, community ranking, dividends, valuation and analyst recommendations. Does the media prefer DCGO or HEC? In the previous week, DocGo had 8 more articles in the media than Hudson Executive Investment. MarketBeat recorded 8 mentions for DocGo and 0 mentions for Hudson Executive Investment. DocGo's average media sentiment score of 0.32 beat Hudson Executive Investment's score of 0.00 indicating that DocGo is being referred to more favorably in the media. Company Overall Sentiment DocGo Neutral Hudson Executive Investment Neutral Do insiders and institutionals hold more shares of DCGO or HEC? 56.4% of DocGo shares are owned by institutional investors. Comparatively, 73.4% of Hudson Executive Investment shares are owned by institutional investors. 2.7% of DocGo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community favor DCGO or HEC? DocGo received 45 more outperform votes than Hudson Executive Investment when rated by MarketBeat users. CompanyUnderperformOutperformDocGoOutperform Votes4575.00% Underperform Votes1525.00% Hudson Executive InvestmentN/AN/A Which has higher earnings and valuation, DCGO or HEC? DocGo has higher revenue and earnings than Hudson Executive Investment. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDocGo$694.97M0.70$6.86M$0.2817.11Hudson Executive InvestmentN/AN/A-$27.24MN/AN/A Is DCGO or HEC more profitable? DocGo has a net margin of 4.35% compared to Hudson Executive Investment's net margin of 0.00%. DocGo's return on equity of 8.90% beat Hudson Executive Investment's return on equity.Company Net Margins Return on Equity Return on Assets DocGo4.35% 8.90% 5.72% Hudson Executive Investment N/A -337.48%-4.06% Do analysts rate DCGO or HEC? DocGo presently has a consensus price target of $6.10, suggesting a potential upside of 27.35%. Given DocGo's stronger consensus rating and higher probable upside, equities analysts plainly believe DocGo is more favorable than Hudson Executive Investment.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Hudson Executive Investment 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryDocGo beats Hudson Executive Investment on 12 of the 13 factors compared between the two stocks. Get Hudson Executive Investment News Delivered to You Automatically Sign up to receive the latest news and ratings for HEC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HEC vs. The Competition Export to ExcelMetricHudson Executive InvestmentHealth Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$124.41M$1.04B$5.84B$9.13BDividend YieldN/A2.04%4.75%3.86%P/E RatioN/A51.2426.7919.19Price / SalesN/A3.67434.5471.84Price / CashN/A26.1438.0134.83Price / Book25.042.937.644.62Net Income-$27.24M-$5.50M$3.19B$246.06M Hudson Executive Investment Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HECHudson Executive InvestmentN/A$3.01-8.7%N/A+28.4%$124.41MN/A0.00N/AGap UpHigh Trading VolumeDCGODocGo2.3633 of 5 stars$5.54-0.4%$6.10+10.1%+40.5%$565.36M$694.97M19.794,164Upcoming EarningsINNVInnovAge1.3738 of 5 stars$3.39-2.0%$5.00+47.5%-35.3%$458.46M$763.85M-17.842,350EUDAEUDA Health0.41 of 5 stars$4.26+3.9%N/A+178.0%$104.92M$3.71M0.002PIIIP3 Health Partners3.27 of 5 stars$0.23-3.8%$2.38+932.6%-79.8%$82.53M$1.48B-0.27500KDLYKindly MDN/A$2.89+15.6%N/AN/A$17.28MN/A0.00N/AHigh Trading VolumeVSEEVsee HealthN/A$1.87+7.5%N/AN/A$6.73MN/A0.00N/AHigh Trading VolumeATPCAgape ATPN/A$0.95+3.3%N/A-85.9%$3.79M$1.35M-1.3040UPHLUpHealthN/A$0.00flatN/A-99.9%$4,000.00$130M0.001,750BTTXBetter TherapeuticsN/AN/AN/A-99.8%$0.00N/A0.0040Gap UpLFSTLifeStance Health Group1.5295 of 5 stars$7.97-0.3%$8.70+9.2%+23.0%$3.05B$1.21B-30.659,325Upcoming EarningsNews CoveragePositive News Related Companies and Tools Related Companies DocGo Alternatives InnovAge Alternatives EUDA Health Alternatives P3 Health Partners Alternatives Kindly MD Alternatives Vsee Health Alternatives Agape ATP Alternatives UpHealth Alternatives Better Therapeutics Alternatives LifeStance Health Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HEC) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hudson Executive Investment Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hudson Executive Investment With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.